A new locus for autosomal dominant intracranial aneurysm, ANIB4, maps to chromosome 5p15.2-14.3
- 1Faculté de Médecine, Université de Montréal, Centre de recherche du CHUM, Hôpital Notre-Dame, Montreal, Quebec, Canada
- 2Department of Human Genetics, McGill University, Montreal, Quebec, Canada
- 3Faculté de Médecine, Université de Montréal, Montreal Heart Institute, Montréal, Quebec, Canada
- 4Division of Neurosurgery, Toronto Western Hospital, University of Toronto, Toronto, Canada
- Correspondence to: Dr Guy A Rouleau Centre de recherche du CHUM, Hôpital Notre-Dame, 1560 rue Sherbrooke Est, Bureau Y-3633, Montréal, Québec, Canada H2L 4M1; guy.rouleau{at}umontreal.ca
- Accepted 12 July 2005
- Revised 14 June 2005
Abstract
Background: Intracranial aneurysms (IA) are dilatations of intracranial arteries that occur most commonly at arterial bifurcations. Unruptured IA are present in approximately 1–2% of the population aged over 30 years of age. Aneurysms are only rarely symptomatic unless they rupture, which typically results in a subarachnoid haemorrhage associated with high morbidity and mortality.
Methods: A large French Canadian (FC) family (Aneu60) was identified which contained 12 affected individuals with intracranial aneurysms. Nine of the affected patients and three unaffected individuals were sent for an 8 cM genome-wide scan. Multipoint and two-point methods were used to analyse the scan data by using a dominant parametric model.
Results: We identified an IA susceptibility locus (ANIB4) located on chromosome 5p15.2-14.3. The locus was found by genome-wide linkage analysis and follow up analyses provided a maximum multipoint LOD score of 3.57 over the region. An identical haplotype segment of 7.2 Mb was found in a second FC pedigree and contributes to the refinement of the candidate gene interval.
Conclusions: Our results indicate that there is a major gene locus on chromosome 5p.
- FC, French Canadian
- HLOD, heterogeneity score
- IA, intracranial aneurysms
- MRA, magnetic resonance angiography
- SAH, subarachnoid haemorrhage
Footnotes
-
DJV is supported by an FRSQ-FCAR scholarship. GAR is supported by the CIHR, the FRSQ, and the NIH.
-
Competing interests: none declared
-
Ethics approval: this study was approved by the Montreal General Hospital Research Ethics Committee, Quebec, Canada








